Roflumilast Impurity DP 2

Roflumilast Impurity DP 2

Roflumilast Impurity DP 2 (CAS No. 1391052-76-8) is an impurity of Roflumilast. Roflumilast reduces inflammation within the lungs which results in COPD(chronic obstructive pulmonary disease). Roflumilast is employed to forestall the worsening of symptoms in individuals with severe COPD.

Additional information on CAS 1391052-76-8

Catalogue No.

VL640002
CAS No.

1391052-76-8
Molecular Formula

C13H8Cl2F2N2O3
Molecular Weight

349.12
Parent drug

Roflumilast
IUPAC Name

N-(3, 5-dichloropyridin-4-yl)-4-(difluoromethoxy)-3-hydroxybenzamide
Synonyms

Roflumilast Related Compound B; 3-(Hydroxy)-N-(3, 5-dichloro-4-pyridinyl)-4-(difluoromethoxy)benzamide
References

“Sci-Hub, Roflumilast in Symptomatic Chronic Obstructive Pulmonary Disease: Two Randomised Clinical Trials. The Lancet, 374(9691), 685–694, 10.1016/S0140-6736(09)61255-1.” Hkvisa.net, 2022, sci-hub.hkvisa.net/www.sciencedirect.com/science/article/abs/pii/S0140673609612551.
Status

In-stock

Other products related to roflumilast

[rfq_list]

Login first to add product to RFQ List

Request a quote

Roflumilast Impurity DP 2

Roflumilast Impurity DP 2
Catalogue No.

VL640002
CAS No.

1391052-76-8
Molecular Formula

C13H8Cl2F2N2O3
Molecular Weight

349.12
Parent drug

Roflumilast
IUPAC Name

N-(3, 5-dichloropyridin-4-yl)-4-(difluoromethoxy)-3-hydroxybenzamide
Synonyms

Roflumilast Related Compound B; 3-(Hydroxy)-N-(3, 5-dichloro-4-pyridinyl)-4-(difluoromethoxy)benzamide
References

“Sci-Hub, Roflumilast in Symptomatic Chronic Obstructive Pulmonary Disease: Two Randomised Clinical Trials. The Lancet, 374(9691), 685–694, 10.1016/S0140-6736(09)61255-1.” Hkvisa.net, 2022, sci-hub.hkvisa.net/www.sciencedirect.com/science/article/abs/pii/S0140673609612551.
Status

In-stock
ListName

Roflumilast Impurity DP 2
Exclusively Supplied by Veeprho

Exclusively Supplied by Veeprho

"*" indicates required fields

Hidden
Products quotation
Name
Url
 
Hidden